ARA-290
Cibinetide
An 11-amino-acid non-erythropoietic peptide derived from erythropoietin that selectively activates the innate repair receptor, studied for anti-inflammatory and tissue-protective effects, including sarcoidosis-associated small-fiber neuropathy.
Half-life
Short; ~2 min (IV), ~10-20 min terminal (subcutaneous). Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied lyophilized; store cool, reconstitute before use, then refrigerate and protect from light.
References
- Peer-reviewed EPO-derived receptor pharmacology
- Phase 2 neuropathy trials
Related in Healing / Recovery
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.